Axi · Сквозной — фон контента (skin) · 16 кат.Axi · Сквозной — фон контента (skin) · 16 кат.

Stock Ratings

UBS Confirms Rating for Summit Therapeutics Shares
EconomicsSep 17
UBS Confirms Rating for Summit Therapeutics Shares
UBS confirmed the rating for Summit Therapeutics shares, indicating confidence in the company's future prospects.
ProspectsUBSRating
Evgenia Sliv